Advertisement
Organisation › Details
Rocket Pharmaceuticals Inc. (Nasdaq: RCKT)
Start | 2015-01-01 established | |
Group | Rocket Pharmaceuticals (Group) | |
Industry | gene therapy | |
Person | Shah, Gaurav (Rocket Pharmaceuticals 202003 CEO) | |
Region | New York, NY | |
Country | United States (USA) | |
Street | 350 Fifth Avenue Empire State Building, Suite 7530 | |
City | 10118 New York, NY | |
Tel | +1-646-440-9100 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | C: 51 to 100 (2020-03-02) |
Currency | USD | |
Profit | -77,270,000 (2019-12-31) | |
Cash | 185,383,000 (2019-12-31) | |
Record changed: 2024-06-07 |
Advertisement
More documents for Rocket Pharmaceuticals (Group)
- [1] Genenta Science S.p.A.. (9/30/21). "Press Release: Genenta Completes Financial Management Team and Appoints Key Advisors Gaurav Shah – Brad Loncar – Alec Ross". Milan & New York, NY....
- [2] MolMed S.p.A.. (3/13/19). "Press Release: Partnership in the Field of Rare Genetic Diseases with Rocket Pharma Extended to Three New Therapeutic Indications". Milan....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top